1 - Rapid onset of action from the first day
2- Superior efficacy as a monotherapy in partial onset seizures &remain seizure-free for at least 1 year
3- Broad spectrum efficacy for all types of seizures as adjunctive therapy
4 - No known clinically significant drug –drug interactions.
5- Long term favorable tolerability with no black box warning
6- Excellent safety profile.